
https://www.metrowestdailynews.com/press-release/story/476281/gideon-korrell-examines-merck-serono-v-hopewell-pharma-ventures-impact-on-by-another/ explains how secondary evidence, not recusal, became the turning point in a high-stakes IPR appeal...
No transcript available.